论文部分内容阅读
目的:研究双时相门冬胰岛素的每天3次注射联合二甲双胍对治疗T2DM患者临床效果。方法:根据我院曾今接收的T2DM患者共80例作为这次研究分析的样本,对患者的治疗前后血糖和糖化红血蛋白进行检查分析。结果:治疗后患者在早午晚3餐前2小时至睡觉前和凌晨的3点时血糖,比治疗之前有所降低(P<0.05);患者在接收治疗后体质有所增强;有1例患者出现了低血糖现象。结论:采用双向门冬胰岛素联合二甲双胍治疗T2DM患者的效果理想,可以降低患者进食后的血糖含量,并且减少因为降低血糖而引发的低血糖症状。
OBJECTIVE: To study the clinical effect of dual-phase aspart-insulin 3 times daily in combination with metformin on T2DM patients. Methods: According to the 80 cases of T2DM patients in our hospital which have been received so far, as the sample of this research and analysis, the blood glucose and glycated red blood protein before and after treatment were examined and analyzed. Results: After treatment, the patients’ blood glucose level decreased from 2 hours before breakfast, 3 hours before meal to 3:00 before going to sleep and before midnight before treatment (P <0.05). The patient’s body constitution increased after receiving the treatment. One case The patient developed hypoglycemia. CONCLUSIONS: The combination of bidirectional insulin aspart and metformin has the best effect in T2DM patients, which can reduce the blood sugar level of the patients after eating and reduce the hypoglycemia symptoms caused by lowering the blood sugar level.